Well if the bid doesn't go through the share price will drop like a stone, so even those who bought at 34.07 could be sitting on a good sized loss.That being said I am confident this is a done deal. I am all in.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025